Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1
Abstract Drug resistance remains a significant challenge in the treatment of pancreatic cancer. The development of drug-resistant cell lines is crucial to understanding the underlying mechanisms of resistance and developing novel drugs to improve clinical outcomes. Here, a novel pancreatic cancer ce...
| Hoofdauteurs: | , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
BMC
2024-07-01
|
| Reeks: | BMC Cancer |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s12885-024-12588-w |